| Literature DB >> 30884891 |
Marina Clemente1, Mariana G Corigliano2, Sebastián A Pariani3, Edwin F Sánchez-López4, Valeria A Sander5, Víctor A Ramos-Duarte6.
Abstract
The serine protease inhibitors (SPIs) are widely distributed in living organisms like bacteria, fungi, plants, and humans. The main function of SPIs as protease enzymes is to regulate the proteolytic activity. In plants, most of the studies of SPIs have been focused on their physiological role. The initial studies carried out in plants showed that SPIs participate in the regulation of endogenous proteolytic processes, as the regulation of proteases in seeds. Besides, it was observed that SPIs also participate in the regulation of cell death during plant development and senescence. On the other hand, plant SPIs have an important role in plant defense against pests and phytopathogenic microorganisms. In the last 20 years, several transgenic plants over-expressing SPIs have been produced and tested in order to achieve the increase of the resistance against pathogenic insects. Finally, in molecular farming, SPIs have been employed to minimize the proteolysis of recombinant proteins expressed in plants. The present review discusses the potential biotechnological applications of plant SPIs in the agriculture field.Entities:
Keywords: molecular farming; pathogen resistance; plants; serine protease inhibitors
Mesh:
Substances:
Year: 2019 PMID: 30884891 PMCID: PMC6471620 DOI: 10.3390/ijms20061345
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Mechanisms of protease-inhibitor interactions. (A) Irreversible “trapping” reactions. The protease–inhibitor interaction induces the cleavage of an internal peptide bond in the inhibitor triggering a conformational change. This reaction is not reversible, and the inhibitor never recovers its initial structure. For this reason, the inhibitors that participate in trapping reactions are also known as suicide inhibitors. The inhibitors never recover the initial structure. (B) Reversible tight-binding interactions. The inhibitor interacts with the protease active site in a similar way to the enzyme-substrate interaction. The protease-inhibitor complex co-exists in a stable equilibrium among the intact form of the inhibitor and the modified forms of the inhibitor where the peptide bond of the reactive site is cleaved. Therefore, the inhibitor in the complex is dissociated to its intact or its modified form. P1: PI reactive site; RL: reactive loop.
Plant protease inhibitors with potential application in agriculture and molecular farming.
| SPI Name | Origen | Role and Function | Biotechnology Application | References |
|---|---|---|---|---|
|
| Inhibitory activity against serine and cysteine protease; effect on mite performance (fecundity and mortality) | Protection against spider mite | [ | |
| AtSerpin1 |
| Inhibition of digestive protease activity; inhibition of larval growth; inhibition of RD21 activity | Protection against insect disease | [ |
| Kunitz type protease inhibitor (AtWSCP) |
| Inhibition of cysteine RD21 activity; controlling cell death | Protection against herbivore attack | [ |
| Potato type 1 inhibitors |
| Differential expression pattern after wounding and nematode infection | Protection against nematodes | [ |
| Bowman-Birk-type inhibitor |
| Arrest fungal invasion; inhibition of fungal growth | Protection against fungal disease | [ |
| Phloem serpin-1 (CmPS-1) |
| Inhibition of elastase activity; increase of the aphid mortality | Protection against insect disease | [ |
| Cowpea trypsin inhibitor gene (CPTI) |
| Inhibition of larval growth | Protection against insect disease | [ |
| Potato carboxypeptidase inhibitor (PCI) |
| Antifungal activity; inhibition of larval growth | Protection against fungal and insect disease | [ |
| Maize proteinase inhibitor (mPI) |
| Inhibition of digestive serine proteinases; inhibition of larval and fungal growth | Protection against fungal and insect disease | [ |
| Soybean Kunitz inhibitor (SKTI) |
| Inhibition of digestive proteases present in insects and parasites | Protection against parasitic and insect disease | [ |
| Soybean Bowman-Birk inhibitor (SbBBI) |
| Inhibition of digestive protease activity; inhibition of aphid growth | Protection against aphid parasitoids | [ |
| Poplar Kunitz trypsin inhibitor | Inhibition of midgut protease present in lepidopteran pests | Protection against insect disease | [ | |
| Passion fruit Kunitz type inhibitors (PfKI) | Inhibition of midgut proteases present in lepidopteran and coleopteran pests and | Protection against insect disease and Control of vectors of neglected tropical diseases | [ | |
| Kunitz trypsin inhibitor (ApKTI) |
| Inhibitory activity against trypsin and papain proteases; inhibition of midgut proteases and larval growth | Protection against insect disease | [ |
| Unusual serine protease inhibitor (UPI) |
| Chymotrypsin inhibitory activity; effect on the fungal and larval growth | Protection against fungal and insect disease | [ |
| Serine proteinase inhibitor (BvSTI) |
| Trypsin inhibitor activity; effect on larval weights | Protection against lepidopteran insect disease | [ |
| Serine protease inhibitor CMe (BTI-CMe) | Barley ( | Inhibition of midgut protease activity; effect on larval growth and survival of insects | Protection against insect disease | [ |
| Potato type I (StPin1A) inhibitor/Potato type II (NaPI) inhibitor |
| Protease inhibitory activity; effect on larval growth | Protection against | [ |
| PI-I and PI-II-class inhibitors |
| Serine protease inhibitory activity | Protection against insect disease | [ |
| Potato Type II Proteinase Inhibitors (SaPIN2b) |
| Inhibition of midgut protease activity | Protection against insect disease | [ |
| Serine protease inhibitor (BWI-1a) |
| Inhibition of spore germination, mycelial growth, bacterial growth and survival of insects | Protection against insect, fungal and bacterial disease | [ |
| Serine protease inhibitors (PSPI-21, PSPI-22) |
| Trypsin and chymotrypsin inhibitory activity; inhibition of mycelial growth | Protection against fungal disease | [ |
| Bowman-Birk-type inhibitor |
| Trypsin and chymotrypsin inhibitory activity; inhibition of mycelial growth | Protection against fungal disease | [ |
| Chymotrypsin/subtilisin inhibitor 2, amylase/subtilisin inhibitor, Bowman-Birk trypsin inhibitor |
| Inhibition of subtilisin and trypsin proteases of | Protection against fungal disease | [ |
| Kazal type inhibitor (AtKPI-1) |
| Inhibition of conidial germination | Protection against fungal disease | [ |
| Tomato cathepsin D inhibitor (CDI) |
| Improvement of the stability of proteins in leaf crude extracts | Achieves high yields of recombinant proteins in the extraction/recovery process | [ |
| Bowman–Birk type protease inhibitor (BBI) |
| Reduction of the degradation of immunoglobulins in the secretion pathway | Achieves high yields of therapeutic proteins in transgenic plants | [ |
| Chymotrypsin and trypsin inhibitor |
| Reduction of the extracellular protease activity | Achieves high yields of recombinant proteins in cell suspension culture | [ |
Figure 2Serine proteases inhibitors identified in plants (endogenous SPIs) or in other organisms (exogenous SPIs) can be introduced by conventional transformation (Agrobacterium tumefaciens or gene gun transformation) or by novel editing technologies to increase the resistance to insect pest and phytopathogenic microorganisms. The application of these technologies can be used to produce new resistant sources of important crops.
Figure 3Co-expression of serine protease inhibitors could help to minimize the proteolytic activity and to avoid the recombinant protein degradation in transplastomic, transgenic plants or in plants that transiently express recombinant proteins. The protease inhibitor can be targeted in the same organelle (chloroplast transformation) where the recombinant protein would be expressed or co-expressed. Transgenic plants over-expressing protease inhibitors would be more suitable to express recombinant proteins by agroinfiltration.